Medico Remedies (Small Cap - Next Multibagger) Share Target 2024, 2025 To 2039
Medico Remedies Limited |
|||
Price: ₹49.98 | |||
52 Week Low: ₹34.80 52 Week High: ₹92.00 |
|||
Market Capital: 379.31 Crore (Smallcap) | |||
Healthcare -> Drug Manufacturers - Specialty & Generic |
Show Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Medico Remedies Share Price Target For 2024
- 1.1.1: Medico Remedies Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: Medico Remedies Share Price Target For 2025
- 1.2.1: Medico Remedies Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Medico Remedies Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: Medico Remedies Brief Company Overview
- 4: Medico Remedies Financial Performance
- 4.0.1: Is Medico Remedies A Good Buy For Long Term?
To predict the Medico Remedies's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Medico Remedies Share Price Target For 2024
The line chart displays the monthly closing prices of Medico Remedies with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Medico Remedies shares in 2024, see the table below.
Medico Remedies Share Price Target Table For 2024
Level | Value | Analysis |
---|---|---|
2024 Target 3 | 52.7 (+5.44%) | Fibonacci Extension Level 100.00% |
2024 Target 2 | 51.82 (+3.68%) | Fibonacci Extension Level 23.60% |
2024 Target 1 | 51.28 (+2.60%) | Price Action: 06 Dec 2024 High |
Current Price | 49.98 | Medico Remedies's share price as of 20 Dec 2024 |
Stop Loss 1 | 49.35 (-1.27%) | Price Action: 18 Dec 2024 Low |
Stop Loss 2 | 48.8 (-2.37%) | Fibonacci Retracement Level 50.00% |
Stop Loss 3 | 48.2 (-3.57%) | Price Action: 12 Dec 2024 Low |
Short-Term Technical Outlook
Current Technical Position: Medico Remedies is showing mixed momentum signals near key moving averages.
Key Technical Level: The 50-day moving average at ₹51.11 serves as the nearest technical reference point.
Historical Returns: 3-month: -2.00% | 6-month: +22.59% | 1-year: -40.36%
Medico Remedies Share Price Target For 2025
The line chart displays the monthly closing prices of Medico Remedies with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Medico Remedies shares in 2025, see the table below.
Medico Remedies Share Price Target Table For 2025
Level | Value | Analysis |
---|---|---|
2025 Target 3 | 90.28 (+80.63%) | Price Action: Chart |
2025 Target 2 | 88.6 (+77.27%) | Price Action: Chart |
2025 Target 1 | 87.72 (+75.51%) | Fibonacci Extension Level 64.90% |
Current Price | 49.98 | Medico Remedies's share price as of 20 Dec 2024 |
Stop Loss 1 | 35.6 (-28.78%) | Fibonacci Retracement Level 98.60% |
Stop Loss 2 | 35.24 (-29.50%) | Price Action: Chart |
Stop Loss 3 | 34.61 (-30.76%) | Price Action: Chart |
Long-Term Technical Outlook
52-Week Range Analysis: Medico Remedies is currently trading at 26.5% of its 52-week range (₹34.8 - ₹92).
Long-Term Trend Analysis: The stock shows mixed long-term signals, trading near key moving averages.
Long-Term Performance: 1-year: -40.36% | 3-year: +115.99% | 5-year: +1,098.56%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Medico Remedies Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
Year | Target 1 | Target 1 YoY Chg % | Target 2 |
---|---|---|---|
Current Price | ₹49.98 | ||
2024 | ₹44.36 | -11.24% | ₹45.03 |
2025 | ₹33.80 | -23.81% | ₹45.30 |
2026 | ₹48.05 | +42.16% | ₹49.40 |
2027 | ₹48.63 | +1.21% | ₹53.21 |
2028 | ₹51.17 | +5.22% | ₹51.94 |
2029 | ₹46.46 | -9.20% | ₹52.51 |
2030 | ₹47.64 | +2.54% | ₹51.80 |
2031 | ₹45.53 | -4.43% | ₹51.10 |
2032 | ₹46.05 | +1.14% | ₹50.40 |
2033 | ₹48.42 | +5.15% | ₹49.15 |
2034 | ₹43.95 | -9.23% | ₹49.69 |
2035 | ₹45.03 | +2.46% | ₹48.99 |
2036 | ₹43.01 | -4.49% | ₹48.28 |
2037 | ₹43.48 | +1.09% | ₹47.58 |
2038 | ₹45.68 | +5.06% | ₹46.37 |
2039 | ₹40.14 | -12.13% | ₹46.87 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Medico Remedies Brief Company Overview
Medico Remedies Limited: A Comprehensive Overview Established in 1994, Medico Remedies Limited is an esteemed Indian pharmaceutical company known for its diverse product range and commitment to healthcare excellence. Key Products: Antibiotics, anti-infectives,...
vitamins, cardiovascular products, antidepressants, antimalarials, syrups, ointments, anti-diabetics, etc. Market Presence: Established in Mumbai, India, with extensive exports globally. Medico Remedies Limited is widely recognized for its high-quality formulations and unwavering commitment to patient well-being.Medico Remedies Financial Performance
Metric | Value | Description |
---|---|---|
Market Capital | 379.31 Crore | Market valuation of Medico Remedies's shares. |
Revenue (TTM) | 144.24 Crore | Total revenue generated by Medico Remedies over the past twelve months. |
Net Income (TTM) | +85,496,000.00 | Net Profit or Loss after all the expenses over the past twelve months. |
Operating Margin | +6.68% | Income from operations as a percentage of revenue, before taxes and interest. |
Profit Margin | +5.92% | Net income as a percentage of revenue, after all expenses. |
Revenue Growth (Quarterly) |
-2.10% | Change in revenue compared to the previous quarter. |
Earnings Growth (YOY Quarterly) |
+19.60% | Change in earnings compared to the same quarter last year. |
Debt-to-Equity (D/E) Ratio |
15.37 | Company's total debt divided by total shareholder equity. |
Total Debt | 8.05 Crore | Sum of Medico Remedies's current & long-term financial obligations. |
Total Cash | 1.54 Crore | Total amount of liquid funds available to Medico Remedies. |
Beta | 0.15 | Beta is less than 1 indicating that the Medico Remedies's price is less volatile than the market. |
Is Medico Remedies A Good Buy For Long Term?
No valid response content found
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.